Advertisement

Topics

Study defines biomarker in response to treatment of castration-resistant prostate cancer

21:34 EST 13 Nov 2018 | News-Medical.net

The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated with two different therapies: taxanes or hormone treatment. Until this day there are no comparative studies between the two and the decision on which treatment to use is done empirically and based on the patient's preferences.

Original Article: Study defines biomarker in response to treatment of castration-resistant prostate cancer

NEXT ARTICLE

More From BioPortfolio on "Study defines biomarker in response to treatment of castration-resistant prostate cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...